Longevity Gene Therapy
Editing the biology of aging at its source.
Gene therapy delivers longevity-associated genes directly into the body to slow, halt, or reverse age-related decline — rather than treating symptoms downstream. It is among the most ambitious areas in the field.
The science
Certain genes are strongly associated with longevity and tissue repair. Gene-therapy interventions use vectors to introduce or upregulate these genes, aiming to shift the body toward a more youthful, resilient state.
Because gene therapy is powerful, the investigational cohorts EverLife Lab tracks place heavy emphasis on safety, dosing, and long-term monitoring, studying targets linked to muscle, cardiovascular, and metabolic aging.
Why it matters
- Aims to address aging at the genetic level
- Targets longevity-associated genes and repair pathways
- Rigorous safety and long-term monitoring protocols
- Backed by specialized gene-therapy partner labs
Frequently asked questions
How does longevity gene therapy work?
It uses delivery vectors to introduce or boost genes associated with longevity and repair, aiming to slow or reverse age-related decline.
Is gene therapy safe?
It is powerful and still investigational, so cohorts emphasize careful dosing, screening, and long-term safety monitoring.
Can I join a gene-therapy cohort?
EverLife Lab members receive priority pre-registration to vetted gene-therapy cohorts run by independent partner labs.
Get priority access to vetted cohorts
EverLife Lab members receive priority pre-registration to investigational longevity cohorts operated by independent partner labs, matched to their tier. Protocol names, partner labs, and registration details are reserved for members.